A consensus conference convened by the Society of Sarcopenia, Cachexia and Wasting Disorders has concluded that "Sarcopenia, ie, reduced muscle mass, with limited mobility" should be considered an important clinical entity and that most older persons should be screened for this condition. "Sarcopenia with limited mobility" is defined as a person with muscle loss whose walking speed is equal to or less than 1 m/s or who walks less than 400 m during a 6-minute walk, and who has a lean appendicular mass corrected for height squared of 2 standard deviations or more below the mean of healthy persons between 20 and 30 years of age of the same ethnic group. The limitation in mobility should not clearly be a result of otherwise defined specific diseases of muscle, peripheral vascular disease with intermittent claudication, central and peripheral nervous system disorders, or cachexia. Clinically significant interventions are defined as an increase in the 6-minute walk of at least 50 meters or an increase of walking speed of at least 0.1 m/s.
展开▼
机译：肌肉减少症，恶病质和浪费性疾病学会召集的共识会议得出结论认为，“肌肉减少症，即肌肉质量降低，活动受限”应被视为重要的临床个体，应该筛查大多数老年人。 “运动能力受限的肌肉减少症”定义为肌肉丧失的人，其步行速度等于或小于1 m / s或在6分钟的步行过程中步行小于400 m，并且其瘦阑尾肿块已校正为高度低于同族20至30岁健康人的平均水平的2个标准差或更多的平方。行动不便的限制不应明确地是由其他特定疾病引起的肌肉疾病，伴有间歇性lau行的周围血管疾病，中枢和周围神经系统疾病或恶病质的结果。临床上重要的干预措施定义为：步行6分钟至少增加50米，或者步行速度至少增加0.1 m / s。
展开▼
